Yelena Bisharyan, PhD

Bio:

Yelena Bisharyan, PhD, is Co-Founder and CEO of Trillion Bio, a drug-delivery company developing a next-generation ionic liquid platform designed to transform the administration of biologic therapeutics. Trillion Bio’s technology aims to enable the shift from intravenous to subcutaneous delivery by improving bioavailability, solubility, and the stability of high-concentration protein formulations.

Previously, Yelena served as Director of Business Development at Harvard University’s Office of Technology Development, where she played a key role in translating breakthrough academic discoveries into new ventures, licensing opportunities, and industry partnerships. Before joining Harvard, she was Vice President of Business Development at TetraGenetics, where she led corporate strategy, business development, and strategic alliances. Her expertise spans biologics strategy, company formation, licensing, high-value transactions, and partnership development.

Dr Bisharyan has more than 20 years of experience spanning biotechnology entrepreneurship, technology commercialization, venture formation, licensing, fundraising, and strategic alliances. She is passionate about translating breakthrough science into medicines that improve patients' lives.